Our findings identified the oncogenic role of PRMT5 in human lung cancer and elucidated a novel mechanism underlying the modulation of the Smad7‐gp130‐STAT3 axis by PRMT5 in those cancer types with aberrantly hyperactivation of STAT3. This evidence concerns the gene STAT3 and lung cancer.